Literature DB >> 22290124

An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model.

R Schmidt-Kastner1, J van Os, G Esquivel, H W M Steinbusch, B P F Rutten.   

Abstract

Investigating and understanding gene-environment interaction (G × E) in a neurodevelopmentally and biologically plausible manner is a major challenge for schizophrenia research. Hypoxia during neurodevelopment is one of several environmental factors related to the risk of schizophrenia, and links between schizophrenia candidate genes and hypoxia regulation or vascular expression have been proposed. Given the availability of a wealth of complex genetic information on schizophrenia in the literature without knowledge on the connections to environmental factors, we now systematically collected genes from candidate studies (using SzGene), genome-wide association studies (GWAS) and copy number variation (CNV) analyses, and then applied four criteria to test for a (theoretical) link to ischemia-hypoxia and/or vascular factors. In all, 55% of the schizophrenia candidate genes (n=42 genes) met the criteria for a link to ischemia-hypoxia and/or vascular factors. Genes associated with schizophrenia showed a significant, threefold enrichment among genes that were derived from microarray studies of the ischemia-hypoxia response (IHR) in the brain. Thus, the finding of a considerable match between genes associated with the risk of schizophrenia and IHR and/or vascular factors is reproducible. An additional survey of genes identified by GWAS and CNV analyses suggested novel genes that match the criteria. Findings for interactions between specific variants of genes proposed to be IHR and/or vascular factors with obstetric complications in patients with schizophrenia have been reported in the literature. Therefore, the extended gene set defined here may form a reasonable and evidence-based starting point for hypothesis-based testing of G × E interactions in clinical genetic and translational neuroscience studies.

Entities:  

Mesh:

Year:  2012        PMID: 22290124     DOI: 10.1038/mp.2011.183

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  48 in total

1.  BDNF rs6265 methylation and genotype interact on risk for schizophrenia.

Authors:  Gianluca Ursini; Tommaso Cavalleri; Leonardo Fazio; Tiziana Angrisano; Luisa Iacovelli; Annamaria Porcelli; Giancarlo Maddalena; Giovanna Punzi; Marina Mancini; Barbara Gelao; Raffaella Romano; Rita Masellis; Francesca Calabrese; Antonio Rampino; Paolo Taurisano; Annabella Di Giorgio; Simona Keller; Letizia Tarantini; Lorenzo Sinibaldi; Tiziana Quarto; Teresa Popolizio; Grazia Caforio; Giuseppe Blasi; Marco A Riva; Antonio De Blasi; Lorenzo Chiariotti; Valentina Bollati; Alessandro Bertolino
Journal:  Epigenetics       Date:  2016-02-18       Impact factor: 4.528

2.  Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis.

Authors:  Eva Velthorst; Jamie Zinberg; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Ricardo E Carrión; Andrea Auther; Barbara A Cornblatt; Thomas H McGlashan; Daniel H Mathalon; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Abraham Reichenberg; Carrie E Bearden
Journal:  Dev Psychopathol       Date:  2017-04-19

Review 3.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

Review 4.  Neurodevelopment, GABA system dysfunction, and schizophrenia.

Authors:  Martin J Schmidt; Karoly Mirnics
Journal:  Neuropsychopharmacology       Date:  2014-04-24       Impact factor: 7.853

Review 5.  Maternal immune activation and abnormal brain development across CNS disorders.

Authors:  Irene Knuesel; Laurie Chicha; Markus Britschgi; Scott A Schobel; Michael Bodmer; Jessica A Hellings; Stephen Toovey; Eric P Prinssen
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

6.  Genome-Wide, Integrative Analysis Implicates Exosome-Derived MicroRNA Dysregulation in Schizophrenia.

Authors:  Yang Du; Yun Yu; Yang Hu; Xiao-Wan Li; Ze-Xu Wei; Rui-Yuan Pan; Xue-Song Li; Guang-En Zheng; Xiao-Yan Qin; Qing-Shan Liu; Yong Cheng
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

7.  Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.

Authors:  Sinan Guloksuz; Lotta-Katrin Pries; Philippe Delespaul; Gunter Kenis; Jurjen J Luykx; Bochao D Lin; Alexander L Richards; Berna Akdede; Tolga Binbay; Vesile Altınyazar; Berna Yalınçetin; Güvem Gümüş-Akay; Burçin Cihan; Haldun Soygür; Halis Ulaş; EylemŞahin Cankurtaran; Semra Ulusoy Kaymak; Marina M Mihaljevic; Sanja Andric Petrovic; Tijana Mirjanic; Miguel Bernardo; Bibiana Cabrera; Julio Bobes; Pilar A Saiz; María Paz García-Portilla; Julio Sanjuan; Eduardo J Aguilar; José Luis Santos; Estela Jiménez-López; Manuel Arrojo; Angel Carracedo; Gonzalo López; Javier González-Peñas; Mara Parellada; Nadja P Maric; Cem Atbaşog Lu; Alp Ucok; Köksal Alptekin; Meram Can Saka; Celso Arango; Michael O'Donovan; Bart P F Rutten; Jim van Os
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

8.  The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia.

Authors:  Amanda Crider; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2016-04-16

9.  O-GlcNAc transferase (OGT) as a placental biomarker of maternal stress and reprogramming of CNS gene transcription in development.

Authors:  Christopher L Howerton; Christopher P Morgan; David B Fischer; Tracy L Bale
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

10.  Vulnerability of synapses in the frontal cortex of mice developmentally exposed to an insecticide: Potential contribution to neuropsychiatric disease.

Authors:  W Michael Caudle
Journal:  Neurotransmitter (Houst)       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.